Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Reference Michael Jack Parente, Balaji Sitharaman, Liquid Chromatography Evaluation of a Novel Graphitic Carbon Stationary Phase Using Glucagon-Like Peptide-1 Analogs , ACS Omega, 2025.
Care should be taken to avoid accidental self-injection: may cause irritation at site of injection
Melanotan 2 at a Glance Melanotan 2 (alpha-MSH Analog) Type: Synthetic analog of alpha-MSH | Primary Target: MC1R (melanocortin 1 receptor) | Secondary Targets: MC3R, MC4R, MC5R | Primary Effect: Skin darkening (eumelanin production) | Secondary Effects: Sexual arousal, appetite suppression | Route: Subcutaneous injection | FDA Status: Not approved | Related: PT-141 (bremelanotide), derived from MT-2 research MT-2 was originally developed at the University of Arizona in the 1990s as a potential preventive treatment for skin cancer
The protocol supports fibroblasts and stimulating collagen in the extracellular matrix
Electrolyte correction
US$ 20.28
US$ 25.70
US$ 29.24
US$ 21.67
US$ 20.10
US$ 25.11
